NO20006431L - Sammensetning for å forhindre og/eller behandle osteoporose og forandringer på grunn av menopausalsyndrom - Google Patents

Sammensetning for å forhindre og/eller behandle osteoporose og forandringer på grunn av menopausalsyndrom

Info

Publication number
NO20006431L
NO20006431L NO20006431A NO20006431A NO20006431L NO 20006431 L NO20006431 L NO 20006431L NO 20006431 A NO20006431 A NO 20006431A NO 20006431 A NO20006431 A NO 20006431A NO 20006431 L NO20006431 L NO 20006431L
Authority
NO
Norway
Prior art keywords
composition
prevent
menopausal syndrome
changes due
treat osteoporosis
Prior art date
Application number
NO20006431A
Other languages
English (en)
Norwegian (no)
Other versions
NO20006431D0 (no
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of NO20006431D0 publication Critical patent/NO20006431D0/no
Publication of NO20006431L publication Critical patent/NO20006431L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
NO20006431A 1998-06-23 2000-12-15 Sammensetning for å forhindre og/eller behandle osteoporose og forandringer på grunn av menopausalsyndrom NO20006431L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT98RM000417A IT1299191B1 (it) 1998-06-23 1998-06-23 Composizione atta a prevenire e trattare l'osteoporosi e le alterazioni legate alla menopausa
PCT/IT1999/000174 WO1999066913A2 (en) 1998-06-23 1999-06-17 Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome, comprising propionyl-l-carnitine and genistein

Publications (2)

Publication Number Publication Date
NO20006431D0 NO20006431D0 (no) 2000-12-15
NO20006431L true NO20006431L (no) 2001-02-22

Family

ID=11406005

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006431A NO20006431L (no) 1998-06-23 2000-12-15 Sammensetning for å forhindre og/eller behandle osteoporose og forandringer på grunn av menopausalsyndrom

Country Status (27)

Country Link
US (1) US6335038B1 (it)
EP (1) EP1089742B1 (it)
JP (1) JP4430233B2 (it)
KR (1) KR20010071541A (it)
CN (1) CN1306434A (it)
AR (1) AR018924A1 (it)
AT (1) ATE228367T1 (it)
AU (1) AU755272B2 (it)
BR (1) BR9911440A (it)
CA (1) CA2334875C (it)
DE (1) DE69904172T2 (it)
DK (1) DK1089742T3 (it)
EE (1) EE200000741A (it)
ES (1) ES2188177T3 (it)
HU (1) HU224957B1 (it)
IL (1) IL140163A0 (it)
IS (1) IS5764A (it)
IT (1) IT1299191B1 (it)
MA (1) MA26655A1 (it)
NO (1) NO20006431L (it)
NZ (1) NZ508877A (it)
PL (1) PL192118B1 (it)
PT (1) PT1089742E (it)
SK (1) SK19292000A3 (it)
TN (1) TNSN99132A1 (it)
TR (1) TR200003735T2 (it)
WO (1) WO1999066913A2 (it)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1302863B1 (it) * 1998-11-13 2000-10-10 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante e preventiva di alterazionitrombotiche e aterosclerotiche comprendente una carnitina ed un
US6476010B2 (en) * 2000-03-10 2002-11-05 Hill's Pet Nutrition Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals
AU2001245977A1 (en) * 2000-03-23 2001-10-03 Interhealth Nutraceuticals Incorporated Method and composition for preventing or reducing the symptoms of menopause
US8669282B2 (en) 2000-10-31 2014-03-11 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
US20020076470A1 (en) 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
IT1317079B1 (it) 2000-12-21 2003-05-26 Sigma Tau Ind Farmaceuti Uso della isovaleril l-carnitina per la preparazione di un medicamentoper la prevenzione e cura dell'osteoporosi.
EA006429B1 (ru) * 2001-03-09 2005-12-29 Сосьете Де Продюи Нестле С.А. Композиция для предупреждения или восстановления возрастных функциональных дефицитов у млекопитающих и способ ее применения
ES2289097T3 (es) * 2001-03-15 2008-02-01 Dsm Ip Assets B.V. Composicion para la prevencion de la osteoporosis consistente de una combinacion de isoflavonas y acidos grasos poliinsaturados.
AUPR957001A0 (en) * 2001-12-19 2002-01-24 Novogen Research Pty Ltd Isoflavone conjugates, derivatives thereof and therapeutic methods involving same
US20050090457A1 (en) * 2002-02-15 2005-04-28 N.V. Nutricia Method of treating mammals with genistein and/or genistein analogues
KR100542478B1 (ko) * 2002-08-28 2006-01-11 한경대학교 산학협력단 석류 유래 피토에스트로겐을 함유하는 건강기능식품
CA2498141C (en) * 2002-09-09 2012-07-10 Nestec S.A. Orally administrable composition for improving skin quality
KR100520408B1 (ko) * 2003-03-25 2005-10-10 주식회사 태평양 비만개선용 조성물
PL2218342T3 (pl) * 2003-05-27 2019-01-31 Dsm Ip Assets B.V. Nowe kompozycje nutraceutyczne i ich zastosowanie
JP2005187454A (ja) * 2003-12-05 2005-07-14 Sankyo Co Ltd ビタミンｅ含有ｌｄｌ低下剤及び／又は動脈硬化抑制剤組成物
JP2007519678A (ja) * 2004-01-28 2007-07-19 ネステク ソシエテ アノニム 皮膚状態を改良しそして皮膚病を予防するための栄養組成物
CN1842327B (zh) * 2004-02-03 2011-05-11 株式会社红豆杉 将源于云南红豆杉的异紫杉脂素作为成分的骨质疏松症预防、治疗药
US8193240B2 (en) * 2004-03-17 2012-06-05 Nestec S.A. Compositions and methods for reducing or preventing obesity
CN100351248C (zh) * 2004-07-05 2007-11-28 南京大学 染料木素衍生物及其制法和用途
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells
DE102004060314A1 (de) * 2004-12-08 2006-08-31 Beiersdorf Ag Wirkstoffkombinationen aus einem oder mehreren Isoflavonoiden und Carnitin und/oder einem oder mehreren Acyl-Carnitinen
RU2354136C1 (ru) 2004-12-29 2009-05-10 Хилл`С Пет Ньютришн, Инк. Способ ингибирования ухудшения обучаемости и/или памяти у животных
KR20070103379A (ko) * 2005-01-10 2007-10-23 호르모스 메디칼 리미티드 에스트로겐 결핍증에 관련된 증상을 예방 또는 완화시키기위한 조성물의 제조를 위한 리그난의 용도
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
EP1904044B1 (en) * 2005-07-08 2013-03-27 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Use of a combination comprising l-carnitine or alkanoyl l-carnitine, lipid solubl benzoquinone and omega-3-polyunsaturated fatty acid for the preparation of a dietary supplement or medicament for the treatment of corneal diseases
BRPI0613000A2 (pt) 2005-07-14 2012-12-04 Hills Pet Nutrition Inc método para aumentar a longevidade de um animal, artigo de fabricação, kit, e, meio de comunicação de informação acerca de ou instruções para a administração a um animal velho de uma composição
CN1939534B (zh) * 2005-09-27 2010-12-01 长春金赛药业股份有限公司 含有人生长激素或人粒细胞巨噬细胞刺激因子的用于治疗损伤和溃疡的外用制剂
JP2009511523A (ja) * 2005-10-14 2009-03-19 ディーエスエム アイピー アセッツ ビー．ブイ． レスベラトロールを含むニュートラシューティカル組成物の新規な使用
AU2006310690B2 (en) 2005-11-02 2012-05-31 Société des Produits Nestlé S.A. Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use
CA2643973A1 (en) * 2006-02-28 2007-09-07 Council Of Scientific And Industrial Research Pharmaceutical composition containing butea isoflavones for the prevention /treatment of bone disorders and a process for the preparation thereof
JP5227195B2 (ja) * 2006-02-28 2013-07-03 ネステク ソシエテ アノニム 骨成長の誘発及び骨損失の抑制のための組成物及び方法
WO2007116052A1 (en) * 2006-04-12 2007-10-18 Unilever Plc Oral composition comprising dha and genistein for enhancing skin properties
EP2004160B1 (en) * 2006-04-12 2012-09-19 Unilever PLC Oral composition with an antiageing effect on the skin
ES2391305T3 (es) * 2006-04-12 2012-11-23 Unilever N.V. Composición oral que comprende un ácido graso poliinsaturado y ácido salicílico para obtener un efecto antiinflamatorio en la piel
US20080108696A1 (en) * 2006-08-02 2008-05-08 Brinton Roberta D Phytoestrogenic Formulations for Alleviation or Prevention of Neurodegenerative Diseases
US8680140B2 (en) * 2006-08-02 2014-03-25 University Of Southern California Phytoestrogenic formulations for alleviation or prevention of menopausal symptoms
US20080200441A1 (en) * 2007-02-14 2008-08-21 University Of Southern California Estrogen receptor modulators associated pharmaceutical compositions and methods of use
KR101645752B1 (ko) 2008-09-10 2016-08-04 아사히 가라스 가부시키가이샤 신규의 프로스타글란딘 ｉ2 유도체
US20110091435A1 (en) * 2008-10-24 2011-04-21 University Of Southern California Phytoestrogenic formulations for alleviation or prevention of hair loss
AU2009315771A1 (en) * 2008-11-11 2010-05-20 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Compound useful for treating cellulite
KR101158856B1 (ko) 2009-05-12 2012-06-25 한국생명공학연구원 콩잎 추출물 또는 이의 분획물을 유효성분으로 함유하는 비만, 고지혈증, 동맥경화, 지방간, 당뇨 또는 대사증후군의 예방 또는 치료용 조성물
KR101760970B1 (ko) * 2010-03-08 2017-07-24 가껭세이야꾸가부시기가이샤 신규의 ep4 아고니스트
KR20130089158A (ko) * 2010-06-16 2013-08-09 시구마-토우인더스트리에파아마슈우티히리유니트에스.피이.에이. 신경 조직에서 신경발생을 증가시키기 위한 방법에 사용하기 위한 아세틸-카르니틴
WO2012011572A1 (ja) * 2010-07-23 2012-01-26 国立大学法人大阪大学 拡張不全型心不全治療薬
IT201700116392A1 (it) * 2018-04-03 2019-10-03 Composizione per somministrazione orale aventi benefico effetto sulla salute della donna in menopausa

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1275434B (it) * 1995-05-19 1997-08-07 Farmila Farma Milano Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
US5702752A (en) * 1996-03-13 1997-12-30 Archer Daniels Midland Company Production of isoflavone enriched fractions from soy protein extracts
US6139872A (en) * 1996-08-14 2000-10-31 Henkel Corporation Method of producing a vitamin product
JP2001511153A (ja) * 1997-02-04 2001-08-07 ブイ． コスバブ，ジョン 血管変性性疾患の予防および処置のための組成物および方法

Also Published As

Publication number Publication date
SK19292000A3 (sk) 2001-08-06
EE200000741A (et) 2002-04-15
NO20006431D0 (no) 2000-12-15
JP2002518437A (ja) 2002-06-25
AR018924A1 (es) 2001-12-12
ES2188177T3 (es) 2003-06-16
PT1089742E (pt) 2003-04-30
ITRM980417A0 (it) 1998-06-23
US6335038B1 (en) 2002-01-01
IL140163A0 (en) 2002-02-10
JP4430233B2 (ja) 2010-03-10
AU4390999A (en) 2000-01-10
CA2334875A1 (en) 1999-12-29
CN1306434A (zh) 2001-08-01
HU224957B1 (en) 2006-04-28
DE69904172D1 (de) 2003-01-09
PL345030A1 (en) 2001-11-19
KR20010071541A (ko) 2001-07-28
BR9911440A (pt) 2001-03-20
WO1999066913A2 (en) 1999-12-29
WO1999066913A3 (en) 2000-04-20
NZ508877A (en) 2002-09-27
TNSN99132A1 (fr) 2005-11-10
DE69904172T2 (de) 2003-08-28
EP1089742A2 (en) 2001-04-11
MA26655A1 (fr) 2004-12-20
IS5764A (is) 2000-12-08
CA2334875C (en) 2009-05-12
TR200003735T2 (tr) 2001-03-21
AU755272B2 (en) 2002-12-05
DK1089742T3 (da) 2003-03-24
IT1299191B1 (it) 2000-02-29
HUP0102879A3 (en) 2002-12-28
ITRM980417A1 (it) 1999-12-23
ATE228367T1 (de) 2002-12-15
PL192118B1 (pl) 2006-09-29
EP1089742B1 (en) 2002-11-27
HUP0102879A2 (hu) 2002-03-28

Similar Documents

Publication Publication Date Title
NO20006431L (no) Sammensetning for å forhindre og/eller behandle osteoporose og forandringer på grunn av menopausalsyndrom
WO2000011968A8 (en) ANTIOXIDANT COMPOSITION COMPRISING ACETYL L-CARNITINE AND α-LIPOIC ACID
NO20006430L (no) Neurobeskyttende sammensetning for forhindring og/eller behandling av nerve- og atferdsforandringer på grunn av angsttilstander eller depresjoner
BR0109912A (pt) Novas combinações antelmìnticas
TR200002770T2 (tr) Estrojene bağlı bozuklukların tedavisi
BR0307126A (pt) Uso de beldroega para tratar rugas faciais
NO20021640L (no) Sammensetning til forebygging og/eller behandling av kretslöpsykdommer som omfatter derivater av L-karnitin ogekstrakter av Gingo biloba
TR200003737T1 (tr) Diyet takviyesi ya da ilaç olarak kullanılan bileşim
NO20013787L (no) Soyaekstrakt som inneholder lipider, fremgangsmåte for dets fremstilling og farmasöytiske og kosmetiske blandinger
WO2000007581A3 (en) Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid
AU5634500A (en) Dietary calcium as a supplement to vitamin d compound treatment of multiple sclerosis
WO2000000183A3 (en) Antioxidant, cytostatic and sustained energy composition which ameliorates the metabolic utilization of glucose comprising acetyl-l-carnitine and a catechin
CA2350220A1 (en) Antioxidant composition comprising propionyl l-carnitine and a flavonoid against thrombosis and atherosclerosis
ATE239504T1 (de) Zusammensetzung zur vorbeugung und/oder behandlung von störungen aufgrund von abnormalen fettstoffmetabolismus, enthaltend l-carnitin und chitosan
US6514527B1 (en) Compositions comprising a mixture of bioflavonols
NO952601L (no) Oligonukleotider for inhibering av ekspresjon av isoprenylprotein-transferaser
ATE339962T1 (de) Zubereitungen zur behandlung von lupus
BR0309055A (pt) Uso combinado de l-carnitina, acetil l-carnitina e propionil l-carnitina para o tratamento da oligoastenoteratospermia
EP1429723A4 (en) TREATMENT EFFECTS OF EXCESSIVE REACTIVE OXYGEN SPECIES
TR200200015T2 (tr) L-Karnitin ve türevleri ile crataegus ekstreleri içeren kardiyoaktif bileşim
EP1319405A1 (en) Composition comprising a mixture of bioflavonols
SE0200256D0 (sv) New composition, methods and use
KR940003550A (ko) 노인성 치매 예방 및 치료방법
MX9709684A (es) Uso de derivados de vitamina d4 para tratamiento de trastornos de la piel.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application